1,2-cyclohexanediamine has been researched along with Ovarian Neoplasms in 2 studies
1,2-cyclohexanediamine: RN given refers to cpd without isomeric designation
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yoshida, M | 1 |
Khokhar, AR | 1 |
Siddik, ZH | 1 |
Schmidt, W | 1 |
Chaney, SG | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Phase II Study of Trastuzumab in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer[NCT01396707] | Phase 2 | 55 participants (Actual) | Interventional | 2011-06-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 other studies available for 1,2-cyclohexanediamine and Ovarian Neoplasms
Article | Year |
---|---|
Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines.
Topics: Animals; Antineoplastic Agents; Cisplatin; Cyclohexylamines; DNA, Neoplasm; Drug Resistance; Female; | 1994 |
Role of carrier ligand in platinum resistance of human carcinoma cell lines.
Topics: Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Cyclohexylamines; DNA Repair; DNA, Neoplasm; Dr | 1993 |